Teva Pharmaceutical Industries Ltd (TEVA) - Product Pipeline Analysis, 2021 Update
Sosei see Teva pipeline cull as an opportunity | pharmaphorum
Teva Pharmaceuticals Near 20-Year Lows (NYSE:TEVA) | Seeking Alpha
Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, a New Once-Daily Formulation of AUSTEDO® (deutetrabenazine) Tablets | Business Wire
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
Teva and Nuvelution partner on Tourette drug development
Generic Drugs in the Pipeline: 2017 Update
Teva Announces FDA Approval of AUSTEDO™ (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington's Disease — Hereditary Neurological Disease Centre
TEVA | Market Realist
FDA's Call on Migraine Drug Could Be Trouble for Teva | Barron's
Teva's AJOVY® Receives EU Approval Offering Patients the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Prophylaxis of Migraine in Adults | Business Wire
Teva: Definitely Undervalued (NYSE:TEVA) | Seeking Alpha
Teva
Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, a New Once-Daily Formulation of AUSTEDO® (deutetrabenazine) Tablets
Teva's pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug | Fierce Pharma
Teva's Key Drugs in Its Specialty Products Pipeline
Teva: We Believe In Biosimilars, But Pipeline And Timing Come First :: Generics Bulletin
ADDING MULTIMEDIA Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ (albuterol sulfate 117 mcg) Inhalation Powder | Business Wire
Teva
EX-99.1
Meet The New Teva: 8% Global Generics Share, 300 ANDAs, 1,500 Launches :: Scrip
Teva leans on Ajovy and Austedo as revenues sink
EX-99.1
Generic NSCLC treatment launched by Teva
